Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07161713 · ClinicalTrials.gov registry record · NA
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
A NA study of Lung Adenocarcinoma and NHL, sponsored by Barbara Nemesure.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07161713 is a NA study of Lung Adenocarcinoma and NHL that is actively recruiting participants, run by Barbara Nemesure. The registered enrollment target is 100 participants, below the 552-participant average among 14 other Lung Adenocarcinoma trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07161713, a NA study of Lung Adenocarcinoma and NHL, is actively recruiting participants, sponsored by Barbara Nemesure.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Cancer survivors can experience health issues that cause chronic illness and lower quality of life. Yoga is a well-known holistic approach to health and overall well-being. Mindfulness has many benefits, including improved focus and less stress. This study aims to evaluate if yoga and/or mindfulness has a positive effect on cancer survivors social, emotional and physical well-being as well as their epigenetics. Epigenetics is how the environment can effect your genes; not by changing our DNA, but by turning genes on or off.
Conditions Studied
Interventions
- BEHAVIORAL Oncology-informed yoga
- BEHAVIORAL SMART
Study Locations (1)
New York
- Stony Brook University Cancer Center - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-09-17 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07161713
The ClinicalTrials.gov registry entry for NCT07161713 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 552-participant average among 14 other Lung Adenocarcinoma trials with a reported enrollment target (82% lower). The listed sponsor is Barbara Nemesure, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Lung Adenocarcinoma appearing as the primary indexed condition, and to 2 interventions - of which Oncology-informed yoga is the first listed.
NCT07161713 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07161713 about?
NCT07161713 is a clinical study titled "SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors". Cancer survivors can experience health issues that cause chronic illness and lower quality of life. Yoga is a well-known holistic approach to health and overall well-being. Mindfulness has many benefits, including improved focus and less stress. This study aims to evaluate if yoga and/or mindfulness...
What is the current status of trial NCT07161713?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-09-17. Estimated completion is 2027-09-30.
What conditions does trial NCT07161713 study?
This clinical trial studies the following conditions: Lung Adenocarcinoma, NHL, Lung Cancer (Diagnosis), Lung Adenocarcinoma Metastatic, Lung Adenocarcinoma Stage IIIB/IV.
What interventions are being tested in trial NCT07161713?
The interventions under investigation include: Oncology-informed yoga (BEHAVIORAL), SMART (BEHAVIORAL).
Who is sponsoring clinical trial NCT07161713?
This trial is sponsored by Barbara Nemesure, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07161713 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Engagement of Veterans With Lung Cancer
RECRUITING · NA
-
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
RECRUITING · NA
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
RECRUITING · Phase 1
-
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
RECRUITING · Phase 2
-
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.